News & Analysis as of

Executive Orders › Anti-Competitive › Regulatory Agenda

Carlton Fields

Implementing Executive Order, FTC Calls on Public and Regulated Community to Identify Anticompetitive Regulations for Potential...

Carlton Fields on

The second Trump administration has issued a slew of deregulatory measures aimed at turbocharging the reduction of regulatory bloat (EO 14192, requiring the repeal of 10 regulations for every new one issued), ensuring...more

Wiley Rein LLP

Trump Directs FTC to Lead Government-Wide Rescission and Modification of Anticompetitive Federal Regulations

Wiley Rein LLP on

On April 9, 2025, President Trump issued an Executive Order directing the Federal Trade Commission (FTC) to lead a process for identifying and rescinding or modifying anticompetitive federal regulations that “reduce...more

Hogan Lovells

Trump Administration Calls for Additional Deregulatory Action

Hogan Lovells on

Last week, President Trump issued several actions, including executive orders and instructions to agencies, that direct agency heads to review and repeal regulations deemed unlawful or anti-competitive. The actions further...more

NAVEX

Healthcare Organizations are Facing Increased Scrutiny – Here's What You Need to Know

NAVEX on

2024 is shaping up to be a very active year for regulatory and enforcement developments in the healthcare industry – developments that concern not just hospitals and nursing facilities, but many non-healthcare companies as...more

Spilman Thomas & Battle, PLLC

President Biden and the FTC Seek to Put the Final Nail in the Coffin for Non-Compete Agreements

Spilman Thomas & Battle, PLLC on

On January 5, 2023, the Federal Trade Commission (“FTC”) published a notice of a proposed rulemaking that would prohibit employers from enforcing non-compete agreements against all employees and would preempt state laws that...more

Jones Day

Executive Order on Promoting Competition in the American Economy: A Focus on Patent and Drug Law to Reduce Health Care Spending

Jones Day on

Each year, Americans spend more than $1,500 per person on prescription drugs. Critics calling for measures to lower prescription drug costs often cast blame on alleged abuses of patent and competition laws. To address these...more

Akerman LLP - HR Defense

Biden Order: Consider a Federal Rule on Non-Competes

Akerman LLP - HR Defense on

Don’t be misled: President Biden’s July 9 Executive Order does not bar non-compete agreements. Rather, it “encourages” the Chair of the Federal Trade Commission to use rule-making to limit their use....more

7 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide